CASI Pharmaceuticals, Inc.
USD0.15
+0.00 (+3.08%)
CEO
David A. Cory
IPO Date
1996-06-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.15
Prev. Close
$0.15
Day Low
$0.15
Day High
$0.15
52W Low
$0.14
52W High
$3.09
Market Cap
$0.00B
Volume
0.01M
| $1.69 |
| 18 Mar 2026 | Huang James | director | Disposed | 10,000 | $2.69 |
| 18 Mar 2026 | Huang James | director | Disposed | 101,571 | $1.93 |
| 9 Sept 2022 | Zukiwski Alexander A | EVP and Chief Medical Officer | A-Award | Acquired | 3,000 | $15.20 |
| 8 Sept 2022 | Huang James | director: | P-Purchase | Acquired | 33,300 | $4.28 |
| 2 Sept 2022 | Huang James | director: | P-Purchase | Acquired | 400 | $3.74 |
| 26 Aug 2022 | Huang James | director: | P-Purchase | Acquired | 39,527 | $3.75 |
| 23 Aug 2022 | Huang James | director: | P-Purchase | Acquired | 40,000 | $3.50 |
| 17 Jun 2022 | He Wei-Wu | director, 10 percent owner, officer: Chairman and CEO | P-Purchase | Acquired | 50,000 | $3.18 |